Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda

Creswell, Jacob; Sahu, Suvanand; Sachdeva, Kuldeep Singh; Diţiu, Lucica; Barreira, Dráurio; Mariandyshev, Andrei; Chen, Ming-Ting; Pillay, Yogan

doi:10.2471/blt.13.133116

Cited by 23 publications

(21 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Combined, BRICS accounts for 46 percent of global incident cases of TB, and 40 percent of global mortality (Creswell et al 2014). All five countries are part of the WHO-designated 'high-burden countries' for multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB (WHO 2014).…”

Section: Brics Health Collaboration Priorities: the Case Of Tuberculomentioning

confidence: 99%

“…In a systematic literature review, Andrew Harmer and colleagues (2013, 1) noted an 'overwhelming tendency to describe individual BRICS countries [sic] influence' (see also Ezziane 2014). Much of the literature has concentrated on country-specific analyses (Lancet 2009(Lancet , 2011a(Lancet , 2011b(Lancet , 2012(Lancet , 2013, investigations of shared health challenges (Creswell et al 2014;Cashwell et al 2014;Ernest et al 2014;Marten et al 2014;Rao et al 2014), or opportunities for technological developments (Ezziane 2014;Kaddar, Milstien, and Schmitt 2014). Several researchers have examined BRICS health initiatives vis-à-vis global health (Fleck and Harmer 2014;Watt, Gomez, and McKee 2014;Buss, Ferreira, and Hoirisch 2014), in large part asking: 'to what extent does it make sense to talk of "the BRICS" as a coherent unit of analysis?'…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

BRICS health and tuberculosis control collaborations during an era of global health

Dirlikov¹

2015

MAT

View full text Add to dashboard Cite

In this think piece, I examine the difference introduced by BRICS (Brazil, Russia, India, China, and South Africa) health collaborations in an era of global health. Using tuberculosis control as a grounding example, I show that BRICS collaborations prioritize: state-led solutions, particularly through policies aimed at expanding universal health coverage; scientific and programmatic innovation; experience and technology sharing; clear benchmarks for progress, based on current best practices of control; and flexibility. Unlike international health, BRICS health collaborations are not primarily concerned with preventing the importation of infectious disease across national borders. Nor are they based on global health's concerns about global biosecurity or humanitarian biomedicine. Rather, BRICS collaborative health efforts fall within the nation-state paradigm, while also aspiring towards the global. They remain flexible in their operation, gesturing towards a neoliberal ethic. This flexibility allows BRICS to work within existing structures, while also establishing their own institutions from which to change traditional assistance relationships.

show abstract

Section: Brics Health Collaboration Priorities: the Case Of Tuberculomentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

BRICS health and tuberculosis control collaborations during an era of global health

Dirlikov¹

2015

MAT

View full text Add to dashboard Cite

show abstract

“…In addition, Brazil, Russia, India, China, and South Africa (BRICS), had 46% of all incident cases of TB and 40% of all TB‐related mortality . With strong economies in BRICS these countries have made strong efforts against TB, which is a leading killer of their citizens . In this context, China is an important funder of TB research .…”

Section: Introductionmentioning

confidence: 99%

Development of tuberculosis vaccines in clinical trials: Current status

Méndez-Samperio¹

2018

Scand J Immunol

View full text Add to dashboard Cite

Tuberculosis (TB) is an important infectious disease worldwide. Currently, Bacillus Calmette-Guérin (BCG) remains the only TB vaccine licensed for human use. This TB vaccine is effective in protecting children against severe military TB but offers variable protective efficacy in adults. Therefore, new vaccines against TB are needed to overcome this serious disease. At present, around 14 TB vaccine candidates are in different phases of clinical trials. These TB vaccines in clinical evaluation can be classified into two groups including preventive pre- and post-exposure vaccines: subunit vaccines (attenuated viral vectors or adjuvanted fusion proteins), and whole-cell vaccines (genetically attenuated Mycobacterium tuberculosis (M. tb), recombinant BCG, killed M. tb or M. vaccae). Although, over the last two decades a great progress in the search for a more effective TB vaccine has been demonstrated there is still no replacement for the licensed BCG vaccine. This article summarizes the current status of TB vaccine development and identifies crucial gaps of research for the development of an effective TB vaccine in all age groups.

show abstract

“…Apparently, the goal was to build health systems with broad coverage 11 in order to ensure better health and to maintain a prominent role in building a global health agenda 12 . Studies have sought to understand the possibilities of joint cooperation between these countries in fields such as the production of drugs and vaccines, in the fight against tuberculosis, as well as in the treatment of HIV/AIDS and historically neglected diseases [13][14][15][16][17] .…”

Section: Introductionmentioning

confidence: 99%

Diferenças e desigualdades no acesso a terapia renal substitutiva nos países do BRICS

Ferraz

Rodrigues

Gatto

et al. 2017

Ciênc. saúde coletiva

View full text Add to dashboard Cite

End-stage renal disease (ESRD) is an important public health problem, especially in developing countries due to the high level of economic resources needed to maintain patients in the different programs that make up renal replacement therapy (RRT). To analyze the differences and inequalities involved in access to RRT in the BRICS countries (Brazil, Russian Federation, India, China and South Africa). This is an applied, descriptive, cross-sectional, quantitative and qualitative study, with documentary analysis and a literature review. The sources of data were from national censuses and scientific publications regarding access to RRT in the BRICS countries. There is unequal access to RRT in all the BRICS countries, as well as the absence of information regarding dialysis and transplants (India), the absence of effective legislation to inhibit the trafficking of organs (India and South Africa) and the use of deceased prisoners as donors for renal transplants (China). The construction of mechanisms to promote the sharing of benefits and solidarity in the field of international cooperation in the area of renal health involves the recognition of bioethical issues related to access to RRT in the BRICS countries.

show abstract

Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda

Cited by 23 publications

References 1 publication

BRICS health and tuberculosis control collaborations during an era of global health

BRICS health and tuberculosis control collaborations during an era of global health

Development of tuberculosis vaccines in clinical trials: Current status

Diferenças e desigualdades no acesso a terapia renal substitutiva nos países do BRICS

Contact Info

Product

Resources

About